Difference between revisions of "Part:BBa K3805326"

 
 
(3 intermediate revisions by one other user not shown)
Line 3: Line 3:
 
<partinfo>BBa_K3805326 short</partinfo>
 
<partinfo>BBa_K3805326 short</partinfo>
  
−
We combined the inhibitory promoter corresponding to the fusion expression substance (AraC) of the target protein (proinsulin) with the DNA sequence of the key site of the target protein (proinsulin) to form a double control switch at the mRNA level
+
We combined three kinds of human insulin proteinogen(https://parts.igem.org/Part:BBa_K3805429, https://parts.igem.org/Part:BBa_K3805001, https://parts.igem.org/Part:BBa_K3805001) with AraC(https://parts.igem.org/Part:BBa_I0500), letting human insulin proteinogen sequence affect the expression of AraC.
  
 
<!-- Add more about the biology of this part here
 
<!-- Add more about the biology of this part here

Latest revision as of 19:05, 21 October 2021


Fusion protein with Human insulin proteinogen and AraC

We combined three kinds of human insulin proteinogen(https://parts.igem.org/Part:BBa_K3805429, https://parts.igem.org/Part:BBa_K3805001, https://parts.igem.org/Part:BBa_K3805001) with AraC(https://parts.igem.org/Part:BBa_I0500), letting human insulin proteinogen sequence affect the expression of AraC.

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]